Bottardi Andrea, Prado Guy F A, Lunardi Mattia, Fezzi Simone, Pesarini Gabriele, Tavella Domenico, Scarsini Roberto, Ribichini Flavio
Division of Cardiology, Cardio-Thoracic Department, University of Verona, 37100 Verona, Italy.
Department of Clinical and Molecular Medicine, Sapienza University, 00185 Rome, Italy.
J Clin Med. 2024 Aug 6;13(16):4600. doi: 10.3390/jcm13164600.
Despite significant goals achieved in diagnosis and treatment in recent decades, coronary artery disease (CAD) remains a high mortality entity and continues to pose substantial challenges to healthcare systems globally. After the latest guidelines, novel data have emerged and have not been yet considered for routine practice. The scope of this review is to go beyond the guidelines, providing insights into the most recent clinical updates in CAD, focusing on non-invasive diagnostic techniques, risk stratification, medical management and interventional therapies in the acute and stable scenarios. Highlighting and synthesizing the latest developments in these areas, this review aims to contribute to the understanding and management of CAD helping healthcare providers worldwide.
尽管近几十年来在冠心病（CAD）的诊断和治疗方面取得了重大进展，但它仍然是一种高致死性疾病，继续给全球医疗系统带来巨大挑战。最新指南发布后，出现了一些新数据，但尚未纳入常规实践考虑范围。本综述的目的是超越指南，深入探讨CAD的最新临床进展，重点关注急性和稳定情况下的非侵入性诊断技术、风险分层、药物治疗和介入治疗。通过突出和综合这些领域的最新进展，本综述旨在促进对CAD的理解和管理，帮助全球医疗服务提供者。
